Key result
The presence of a large left ventricular apical aneurysm was independently associated with an increased risk of adverse outcomes (HR 2.795; 95% CI 1.118-6.986; P=0.028).
Why the study?
Does a large left ventricular apical aneurysm (ACR ≥ 1.5) increase the risk of adverse outcomes compared to a small LVAA in patients with ischemic LVAA?
Cohort (n=70)
Does a large left ventricular apical aneurysm (ACR ≥ 1.5) increase the risk of adverse outcomes compared to a small LVAA in patients with ischemic LVAA?
In patients with ischemic left ventricular apical aneurysm, a large aneurysm (apical conicity ratio ≥ 1.5) is an independent predictor of adverse clinical outcomes including fatal arrhythmia, embolic infarction, and heart failure readmission.
BACKGROUND: Left ventricular apical aneurysm (LVAA) is a serious complication associated with myocardial infarction. However, the effects of a previously formed LVAA on long-term left ventricular (LV) geometry and clinical outcomes have not been fully evaluated. METHODS: From January 2009 to May 2015, we retrospectively identified 70 patients (mean age, 66 ± 12 years; males, 72.9%) with an LVAA due to ischemia. These patients were classified into two groups according to the initial apical conicity ratio (ACR): large LVAA group (ACR ≥ 1.5, n = 40) and small LVAA group (ACR < 1.5, n = 30). An adverse outcome was defined as a composite of fatal arrhythmia, embolic infarction, and readmission due to heart failure. RESULTS: The ACR significantly decreased over the first month and then increased after 1 and 3 years of follow-up. The other examined echocardiographic indexes did not exhibit temporal changes. During the follow-up period (median 1138 days), the large LVAA group experienced a lower event-free survival (P = 0.016). In a multivariate Cox model, the presence of a large LVAA (adjusted hazard ratio [HR] = 2.795, 95% confidence interval [CI] = 1.118-6.986, P = 0.028) and the initial LV ejection fraction (EF) (adjusted HR = 0.964, 95% CI = 0.932-0.997, P = 0.034) were independent predictors of adverse outcomes. CONCLUSIONS: This study demonstrates that LVAAs undergo a dynamic process and that large LVAAs are associated with adverse outcomes. Our results suggest that the ACR could be helpful for predicting adverse outcomes in patients with apical aneurysm.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2016) conducted a cohort in Left ventricular apical aneurysm due to ischemia (n=70). Large left ventricular apical aneurysm (apical conicity ratio ≥ 1.5) vs. Small left ventricular apical aneurysm (apical conicity ratio < 1.5) was evaluated on Composite of fatal arrhythmia, embolic infarction, and readmission due to heart failure (HR 2.795, 95% CI 1.118-6.986, p=0.028). The presence of a large left ventricular apical aneurysm was independently associated with an increased risk of adverse outcomes (HR 2.795; 95% CI 1.118-6.986; P=0.028).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: